An in-depth look to TAKEDA PHARMACEUTICAL CO LTD operating, investing, and financing activities

TAK/N free cash flow for Q3 24 is 43.27 B MXN. For 2023, TAK/N free cash flow was 53.28 B MXN and operating cash flow was 73.39 B MXN.